NovoCure Limited Depreciation
NovoCure Limited (NVCR) reported Depreciation of $9.40 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-02-26
- NovoCure Limited depreciation for the quarter ending 2015-12-31 was -$657.00K.
- NovoCure Limited depreciation for the quarter ending 2014-12-31 was -$578.00K.
- NovoCure Limited depreciation for fiscal 2025 was $9.40M, a 52.38% increase from fiscal 2024.
- NovoCure Limited depreciation for fiscal 2024 was $6.17M, a 56.54% increase from fiscal 2023.
- NovoCure Limited depreciation for fiscal 2023 was $3.94M, a 26.86% increase from fiscal 2022.
- NovoCure Limited depreciation for fiscal 2022 was $3.10M, a 10.42% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|
| 2025-12-31 | $9.40M 10-K · filed 2026-02-26 | ||
| 2024-12-31 | $6.17M 10-K · filed 2026-02-26 | ||
| 2023-12-31 | $3.94M 10-K · filed 2026-02-26 | ||
| 2022-12-31 | $3.10M 10-K · filed 2025-02-27 | ||
| 2021-12-31 | $2.81M 10-K · filed 2024-02-22 | ||
| 2020-12-31 | $2.63M 10-K · filed 2023-02-23 | ||
| 2019-12-31 | $2.08M 10-K · filed 2022-02-24 | ||
| 2018-12-31 | $1.97M 10-K · filed 2021-02-25 | ||
| 2017-12-31 | $1.97M 10-K · filed 2020-02-27 | ||
| 2016-12-31 | $1.67M 10-K · filed 2019-02-28 | ||
| 2015-12-31 | -$657.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $1.35M 10-K · filed 2018-02-22 | |
| 2015-09-30 | $2.00M 10-Q · filed 2015-10-27 | ||
| 2014-12-31 | -$578.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $886.00K 10-K · filed 2017-02-23 | |
| 2014-09-30 | $1.46M 10-Q · filed 2015-10-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |